2011, IT and Specialization - Primary Care Digest

Diabetes related complications among Ethiopian Jews-Outcomes of a 10 years cohort study in Israel [Population health and epidemiology]

Annals of Family Medicine

NOVEMBER 20, 2024

Population: Jewish CHS members, aged 18+, diagnosed with T2D between 2000-2011, born in Israel or Ethiopia. Conclusions: It is imperative to provide specialized care for immigrant populations to enhance the management of chronic diseases and mitigate further morbidity risks. Intervention: 10-year follow-up to track T2D outcomes.

Complication

Complication Diabetes Individual Chronic Disease

Jennifer Newberger Returns to HPM as a Director After Stints with Apple, Abbott Laboratories, and Cognito Therapeutics

FDA Law Blog

MAY 27, 2024

She also specializes in medical device software and digital health. Jennifer was with the firm from 2011-2017, before leaving for in-house roles at Apple, Abbott Laboratories, and Cognito Therapeutics. Hyman, Phelps & McNamara, P.C. Jennifer also helps clients with contract matters, regulatory due diligence, and public filings.

Manufacturing

Manufacturing Management Utilities Relationship

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

DECEMBER 16, 2020

Tsai has seen race-based medicine play out in clinical practice 10:45 What role should race play in making clinical decisions? 13:16 Status of the current conversation on removing race from eGFR calculators: why is it so contentious? Poet Marge Piercy has written, “The work of the world is as common as mud.”

Clinic

Clinic Education Clinical Practice Patient-Centered

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

FDA Law Blog

MAY 3, 2021

However, more recently, we have observed that DEA special agents are also becoming more involved in investigations of registrants, thus, raising the stakes for compliance. Thus, non-compliance can be very costly, so it is more important than ever to dot every “i,” cross every “t.”. DEA can seek administrative action, and working with U.S.

Management

Management Manufacturing Specialization IT

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

FDA Law Blog

MAY 3, 2021

However, more recently, we have observed that DEA special agents are also becoming more involved in investigations of registrants, thus, raising the stakes for compliance. Thus, non-compliance can be very costly, so it is more important than ever to dot every “i,” cross every “t.”. DEA can seek administrative action, and working with U.S.

Management

Management Manufacturing Specialization IT

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

JUNE 16, 2025

The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Food and Drug Administration (FDA). The process could take years. Ibogaine is made from the root of a plant found in Africa. It has been banned in the U.S. Former Texas Gov.

Mental Health

Mental Health IT Medical Specialization

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

Medical Xpress

JUNE 16, 2025

What is known is that special cells in the eye called intrinsically photosensitive retinal ganglion cells (ipRGCs) detect blue light and send signals to the SCN to reset the clock. When we cross time zones and experience jet lag, it happens because our internal clock remains set to the old time zone.

Provider

Provider Complication Medical Diabetes

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog

DECEMBER 3, 2023

As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). We do not address the technical and administrative details of the Discount Program here. Final Guidance at 2.

Manufacturing

Manufacturing Provider IT Electronics

Buprenorphine Use in Serious Illness: A Podcast with Katie Fitzgerald Jones, Zachary Sager and Janet Ho

GeriPal

APRIL 14, 2022

We got some really special guests with us. It’s been around for a long time but is acting like the hot new kid in town. Just look at this year’s AAHPM meeting, where it felt like every other session was talking about how hot buprenorphine is right now. But does this drug really live up to the hype? Transcript. This is Eric Widera.

Illness

Illness Patient-Centered IT Patients

Skinny Label and Induced Infringement: The Saga Continues

FDA Law Blog

MAY 11, 2023

No reasonable jury could have concluded that the carved-out labeling for petitioner’s generic carvedilol from 2007-2011 was itself evidence of intent to induce infringement.” The Government’s brief puts a lot of faith in the existing regulatory system rather than the patent system.

Government

Government Manufacturing IT Utilities

Writing for the Lay Public: Rosanne Leipzig and Louise Aronson

GeriPal

MARCH 16, 2023

We have two authors, books, op-eds, prolific authors, and today’s podcast is a two-part special. How do you find time to write and also be doctors and academic professors? In all seriousness, you don’t actually have to want to write a book to be interested in this podcast. Welcome to the GeriPal podcast, Rosanne. And I loved it.

IT

IT Healthcare Professional Healthcare Transportation

Exploring the Nature of Chronic Pain with Haider Warraich

GeriPal

JULY 7, 2022

Haider: Yeah, this is a special song. We discussed the nature of pain, what makes chronic pain different from acute pain, what’s the difference between proprioception, pain, and suffering, and so much more. Haider is a physician at the Brigham and Women’s Hospital, and the VA in Boston. Welcome back to the GeriPal podcast, Haider.

Patient-Centered

Patient-Centered Physicals IT Patients

FDA Announces it is Ready to Act on Menthol Cigarettes, but its Success is Uncertain

FDA Law Blog

MAY 14, 2021

In 2009, Congress specifically exempted “tobacco or menthol” when it prohibited all other flavored cigarettes under the Family Smoking Prevention and Tobacco Control Act (TCA)’s “ Special Rule for Cigarettes.” TPSAC released a report of its findings in 2011. Federal actions on menthol cigarettes. 21 U.S.C. § 387g(a)(1)(A).

IT

IT Manufacturing Specialization Community

FDA Announces it is Ready to Act on Menthol Cigarettes, but its Success is Uncertain

FDA Law Blog

MAY 14, 2021

In 2009, Congress specifically exempted “tobacco or menthol” when it prohibited all other flavored cigarettes under the Family Smoking Prevention and Tobacco Control Act (TCA)’s “ Special Rule for Cigarettes.” TPSAC released a report of its findings in 2011. Federal actions on menthol cigarettes. 21 U.S.C. § 387g(a)(1)(A).

IT

IT Manufacturing Specialization Community

Into the Ashtray: FDA’s Previous Proposal to Ban Menthol Cigarettes

FDA Law Blog

FEBRUARY 12, 2025

For some background (which is covered in more detail in one of our previous posts on the subject ), in 2009, Congress specifically exempted tobacco or menthol when it prohibited all other flavored cigarettes under the Family Smoking Prevention and Tobacco Control Act (TCA)s Special Rule for Cigarettes. 44,484 (July 24, 2013).

Specialization

Specialization IT Families Family

Primary Care Digest

Diabetes related complications among Ethiopian Jews-Outcomes of a 10 years cohort study in Israel [Population health and epidemiology]

Jennifer Newberger Returns to HPM as a Director After Stints with Apple, Abbott Laboratories, and Cognito Therapeutics

Trending Sources

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

I Hear You Knockin’… Preparing for and Managing DEA Inspections (Part 1)

Texas invests $50M in psychedelic drug research to treat addiction

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

Buprenorphine Use in Serious Illness: A Podcast with Katie Fitzgerald Jones, Zachary Sager and Janet Ho

Skinny Label and Induced Infringement: The Saga Continues

Writing for the Lay Public: Rosanne Leipzig and Louise Aronson

Exploring the Nature of Chronic Pain with Haider Warraich

FDA Announces it is Ready to Act on Menthol Cigarettes, but its Success is Uncertain

FDA Announces it is Ready to Act on Menthol Cigarettes, but its Success is Uncertain

Into the Ashtray: FDA’s Previous Proposal to Ban Menthol Cigarettes

Stay Connected